Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 3:31 pm Sale |
2020-12-31 | 13G | Vapotherm, Inc. VAPO |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-225,509 (Position Closed) |
Filing History |
| 2021-02-16 3:31 pm Sale |
2020-12-31 | 13G | Zogenix, Inc. ZGNX |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-3,709,152 (Position Closed) |
Filing History |
| 2021-02-16 3:30 pm Purchase |
2020-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
PERCEPTIVE ADVISORS LLC | 3,693,516 7.400% |
490,110 (+15.30%) |
Filing History |
| 2021-02-16 3:30 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
PERCEPTIVE ADVISORS LLC | 3,493,607 6.800% |
3,493,607 (New Position) |
Filing History |
| 2021-02-16 3:30 pm Unchanged |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 2,150,641 7.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 3:30 pm Purchase |
2020-12-31 | 13G | DBV Technologies S.A. DBVT |
PERCEPTIVE ADVISORS LLC | 221,106 8.100% |
82,552 (+59.58%) |
Filing History |
| 2021-02-08 5:16 pm Purchase |
2021-01-25 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 3,425,916 9.800% |
3,425,916 (New Position) |
Filing History |
| 2021-02-08 5:15 pm Purchase |
2021-01-28 | 13D | Astria Therapeutics, Inc. ATXS |
PERCEPTIVE ADVISORS LLC | 412,821 10.500% |
412,821 (New Position) |
Filing History |
| 2021-02-08 09:16 am Purchase |
2021-01-28 | 13G | AnaptysBio, Inc. ANAB |
PERCEPTIVE ADVISORS LLC | 1,495,336 5.500% |
1,495,336 (New Position) |
Filing History |
| 2021-01-27 5:03 pm Sale |
2021-01-22 | 13G | Motus GI Holdings, Inc. MOTS |
PERCEPTIVE ADVISORS LLC | 8,868 8.300% |
-5,167 (-36.81%) |
Filing History |
| 2021-01-27 4:35 pm Purchase |
2020-12-21 | 13G | SCYNEXIS, Inc. SCYX |
PERCEPTIVE ADVISORS LLC | 1,300,000 6.800% |
1,300,000 (New Position) |
Filing History |
| 2020-12-17 09:30 am Purchase |
2020-12-10 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 720,257 12.700% |
270,270 (+60.06%) |
Filing History |
| 2020-12-14 08:33 am Purchase |
2020-12-04 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 1,327,481 5.400% |
1,327,481 (New Position) |
Filing History |
| 2020-11-24 08:02 am Purchase |
2020-11-23 | 13D | MeiraGTx Holdings plc MGTX |
PERCEPTIVE ADVISORS LLC | 6,973,737 16.000% |
525,000 (+8.14%) |
Filing History |
| 2020-10-28 5:01 pm Purchase |
2020-10-22 | 13G | IVERIC bio, Inc. ISEE |
PERCEPTIVE ADVISORS LLC | 4,482,713 5.000% |
4,482,713 (New Position) |
Filing History |
| 2020-10-28 5:00 pm Purchase |
2020-10-26 | 13G | BCLS Acquisition Corp. BLSA |
PERCEPTIVE ADVISORS LLC | 1,000,000 7.000% |
1,000,000 (New Position) |
Filing History |
| 2020-10-07 4:30 pm Purchase |
2020-09-29 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 3,586,485 5.000% |
3,586,485 (New Position) |
Filing History |
| 2020-10-01 4:09 pm Purchase |
2020-09-24 | 13G | Protara Therapeutics, Inc. TARA |
PERCEPTIVE ADVISORS LLC | 608,544 5.800% |
608,544 (New Position) |
Filing History |
| 2020-07-13 4:30 pm Purchase |
2020-07-09 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 6,285,458 19.100% |
3,200,000 (+103.71%) |
Filing History |
| 2020-06-11 5:10 pm Purchase |
2020-03-09 | 13G | MENLO THERAPEUTICS INC MNLO |
PERCEPTIVE ADVISORS LLC | 22,876,410 14.000% |
22,876,410 (New Position) |
Filing History |